Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute, 10523 [2018-04766]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 47 / Friday, March 9, 2018 / Notices
of the allegations in the complaint. In
the motion, the complainant states that
there are no other agreements, written or
oral, express or implied between the
parties concerning the subject matter of
the investigation. Respondents and OUII
filed responses in support of the motion.
The ALJ issued the subject ID on
February 5, 2018, granting the
unopposed motion for termination. He
found that the motion satisfied
Commission Rule 210.21(a)(1) (19 CFR
210.21(a)(1)) and that there are no
extraordinary circumstances that
warrant denying the motion. No party
petitioned for review of the subject ID.
The Commission has determined not
to review the ID and has terminated the
investigation.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337, and in part
210 of the Commission’s Rules of
Practice and Procedure, 19 CFR part
210.
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
31, 2017, Research Triangle Institute,
3040 East Cornwallis Road, Hermann
Building, Room 106, Research Triangle
Park, North Carolina 27709–2194
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
By order of the Commission.
Issued: March 6, 2018.
Lisa R. Barton,
Secretary to the Commission.
The company will manufacture
marihuana (7360) and
tetrahydrocannabinols (7370) for use by
their researchers under the above-listed
controlled substances as Active
Pharmaceutical Ingredient (API) for
clinical trials.
In reference to drug code (7370) the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activities for this drug code are
authorized for this registration.
[FR Doc. 2018–04794 Filed 3–8–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Marihuana .....................
Tetrahydrocannabinols
Drug
code
7360
7370
I
I
[FR Doc. 2018–04766 Filed 3–8–18; 8:45 am]
BILLING CODE 4410–09–P
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before May 8, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
amozie on DSK30RV082PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
16:47 Mar 08, 2018
Jkt 244001
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2006–0028]
MET Laboratories, Inc.: Grant of
Expansion of Recognition
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Notice.
AGENCY:
In this notice, OSHA
announces its final decision to expand
the scope of recognition for MET
Laboratories, Inc., as a Nationally
Recognized Testing Laboratory (NRTL).
DATES: The expansion of the scope of
recognition becomes effective on March
9, 2018.
SUMMARY:
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Information regarding this notice is
available from the following sources:
Press inquiries: Contact Mr. Frank
Meilinger, Director, OSHA Office of
Communications, phone: (202) 693–
1999; email: meilinger.francis2@dol.gov.
General and technical information:
Contact Mr. Kevin Robinson, Director,
Office of Technical Programs and
Coordination Activities, Directorate of
Technical Support and Emergency
Management, Occupational Safety and
Health Administration, U.S. Department
of Labor, phone: (202) 693–2110; email:
robinson.kevin@dol.gov. OSHA’s web
page includes information about the
NRTL Program (see https://
www.osha.gov/dts/otpca/nrtl/
index.html).
SUPPLEMENTARY INFORMATION:
Schedule
Dated: March 5, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
Bulk Manufacturer of Controlled
Substances Application: Research
Triangle Institute
ACTION:
Controlled
substance
10523
I. Notice of Final Decision
OSHA hereby gives notice of the
expansion of the scope of recognition of
MET Laboratories, Inc. (MET), as a
NRTL. MET’s expansion covers the
addition of four test standards to its
scope of recognition.
OSHA recognition of a NRTL signifies
that the organization meets the
requirements specified by 29 CFR
1910.7. Recognition is an
acknowledgment that the organization
can perform independent safety testing
and certification of the specific products
covered within its scope of recognition
and is not a delegation or grant of
government authority. As a result of
recognition, employers may use
products properly approved by the
NRTL to meet OSHA standards that
require testing and certification of the
products.
The Agency processes applications by
a NRTL for initial recognition, or for
expansion or renewal of this
recognition, following requirements in
Appendix A to 29 CFR 1910.7. This
appendix requires that the Agency
publish two notices in the Federal
Register in processing an application. In
the first notice, OSHA announces the
application and provides its preliminary
finding and, in the second notice, the
Agency provides its final decision on
the application. These notices set forth
the NRTL’s scope of recognition or
modifications of that scope. OSHA
maintains an informational web page for
each NRTL that details its scope of
recognition. These pages are available
from the Agency’s website at https://
www.osha.gov/dts/otpca/nrtl/
index.html.
MET submitted four applications, one
dated July 7, 2015 (OSHA–2006–0028–
0037), two dated December 14, 2016
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 83, Number 47 (Friday, March 9, 2018)]
[Notices]
[Page 10523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04766]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Research
Triangle Institute
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before May 8, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
31, 2017, Research Triangle Institute, 3040 East Cornwallis Road,
Hermann Building, Room 106, Research Triangle Park, North Carolina
27709-2194 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company will manufacture marihuana (7360) and
tetrahydrocannabinols (7370) for use by their researchers under the
above-listed controlled substances as Active Pharmaceutical Ingredient
(API) for clinical trials.
In reference to drug code (7370) the company plans to bulk
manufacture a synthetic tetrahydrocannabinol. No other activities for
this drug code are authorized for this registration.
Dated: March 5, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-04766 Filed 3-8-18; 8:45 am]
BILLING CODE 4410-09-P
